# CRG

CRG is an Asset Manager based in Houston, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Houston, United States
- **Region:** North America
- **Address:** Boulder, CO, United States
- **Founded:** 2003
- **Assets under management:** $5.8 billion in cumulative capital commitments (per the firm, 2024)
- **Website:** crglp.com
- **LinkedIn:** https://www.linkedin.com/company/crg-corporation

## Regulatory record

- **CRD number:** 132967
- **SEC file number:** 801-63545
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/132967

## About

CRG (CR Group L.P.) is a global healthcare investment firm and leading healthcare private credit firm managing over $4 billion in institutional capital. It invests across consumer health, life sciences, and healthcare services & IT, pursuing credit investments and select equity investments. The firm provides flexible growth capital solutions and is dedicated to improving healthcare.

## Sectors

- Private Credit
- Healthcare Services
- Digital Health
- Medical Devices
- Pharmaceuticals

## Offices

- Houston, TX
- Menlo Park, CA
- London, UK

## People

- Charles Tate — Founder and Chairman
- Jake Macey — President

## Questions

### Where does CRG source its capital?

CRG operates as a business development company and manages separate accounts for institutional investors, meaning it does not raise traditional drawdown funds. The firm's permanent capital base gives it the flexibility to hold loans through maturity rather than returning capital to limited partners on a predefined schedule. This structure is unusual among middle-market direct lenders.

### Which healthcare subsectors does CRG explicitly avoid?

CRG avoids early-stage biotechnology companies whose value depends on binary clinical-trial results, as well as pre-revenue drug-discovery platforms with no near-term regulatory pathway. The firm's credit model depends on commercial cash flows or near-term visibility into reimbursement, which favors medical devices, diagnostics, and healthcare services over pure pharmaceutical R&D.

### Who runs investment decisions at CRG?

Founder Charles Tate chairs the firm and maintains the final investment committee role. Jake Macey, President, runs day-to-day operation of the investment teams across the Boulder, Houston, Menlo Park, and London offices. CRG's credit committee includes partners with direct operating experience inside pharmaceutical and medical device companies.

## Related profiles

- [Toshiba](https://altss.com/profile/toshiba-corporation)

---

Last updated: 2026-08-11T15:06:27.647Z

Canonical page: https://altss.com/profile/crg

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology